CN1262271C - 用于预防或治疗精神病的氨基甲酸酯化合物 - Google Patents

用于预防或治疗精神病的氨基甲酸酯化合物 Download PDF

Info

Publication number
CN1262271C
CN1262271C CNB028089235A CN02808923A CN1262271C CN 1262271 C CN1262271 C CN 1262271C CN B028089235 A CNB028089235 A CN B028089235A CN 02808923 A CN02808923 A CN 02808923A CN 1262271 C CN1262271 C CN 1262271C
Authority
CN
China
Prior art keywords
formula
purposes
enantiomer
schizophrenia
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028089235A
Other languages
English (en)
Chinese (zh)
Other versions
CN1505507A (zh
Inventor
C·R·普拉塔-萨拉曼
赵柏羽
R·E·特伊曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
3 Dimensional Pharmaceuticals Inc
Original Assignee
3 Dimensional Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 Dimensional Pharmaceuticals Inc filed Critical 3 Dimensional Pharmaceuticals Inc
Publication of CN1505507A publication Critical patent/CN1505507A/zh
Application granted granted Critical
Publication of CN1262271C publication Critical patent/CN1262271C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB028089235A 2001-02-27 2002-02-21 用于预防或治疗精神病的氨基甲酸酯化合物 Expired - Fee Related CN1262271C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US60/271,889 2001-02-27
US10/081,761 2002-02-21
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
CN1505507A CN1505507A (zh) 2004-06-16
CN1262271C true CN1262271C (zh) 2006-07-05

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028089235A Expired - Fee Related CN1262271C (zh) 2001-02-27 2002-02-21 用于预防或治疗精神病的氨基甲酸酯化合物

Country Status (25)

Country Link
US (1) US6541513B2 (enExample)
EP (1) EP1401424B1 (enExample)
JP (1) JP4276841B2 (enExample)
KR (1) KR100886578B1 (enExample)
CN (1) CN1262271C (enExample)
AR (1) AR032876A1 (enExample)
AT (1) ATE346597T1 (enExample)
AU (1) AU2002242296B2 (enExample)
BR (1) BR0207829A (enExample)
CA (1) CA2439480C (enExample)
CZ (1) CZ302412B6 (enExample)
DE (1) DE60216457T2 (enExample)
DK (1) DK1401424T3 (enExample)
ES (1) ES2275844T3 (enExample)
HU (1) HUP0303342A3 (enExample)
IL (2) IL157588A0 (enExample)
MX (1) MXPA03007722A (enExample)
NO (1) NO20033801L (enExample)
NZ (1) NZ527991A (enExample)
PL (1) PL365021A1 (enExample)
PT (1) PT1401424E (enExample)
RS (1) RS51056B (enExample)
RU (1) RU2302240C2 (enExample)
TW (1) TWI251486B (enExample)
WO (1) WO2002067927A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2002067925A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
CA2439286A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
DE60232796D1 (de) 2001-07-16 2009-08-13 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
WO2008054984A1 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9907776B2 (en) 2013-03-12 2018-03-06 Bio-Pharm Solutions, Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
JP2955358B2 (ja) * 1989-06-09 1999-10-04 ファルマシア・アンド・アップジョン・カンパニー 中枢神経系活性を有する複素環系アミン
US5492930A (en) 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
RU2003128983A (ru) 2005-03-10
EP1401424A1 (en) 2004-03-31
IL157588A0 (en) 2004-03-28
CA2439480A1 (en) 2002-09-06
AU2002242296B2 (en) 2006-06-29
CZ302412B6 (cs) 2011-05-04
WO2002067927A1 (en) 2002-09-06
NO20033801D0 (no) 2003-08-26
JP4276841B2 (ja) 2009-06-10
AR032876A1 (es) 2003-11-26
DE60216457T2 (de) 2007-09-20
NZ527991A (en) 2005-04-29
EP1401424B1 (en) 2006-11-29
ES2275844T3 (es) 2007-06-16
PT1401424E (pt) 2007-02-28
JP2004523556A (ja) 2004-08-05
DE60216457D1 (de) 2007-01-11
HUP0303342A3 (en) 2012-07-30
NO20033801L (no) 2003-10-22
CN1505507A (zh) 2004-06-16
KR100886578B1 (ko) 2009-03-05
KR20030076713A (ko) 2003-09-26
ATE346597T1 (de) 2006-12-15
RU2302240C2 (ru) 2007-07-10
PL365021A1 (en) 2004-12-27
IL157588A (en) 2009-12-24
HUP0303342A2 (hu) 2004-01-28
TWI251486B (en) 2006-03-21
BR0207829A (pt) 2004-06-22
CZ20032297A3 (cs) 2004-06-16
RS67503A (sr) 2006-12-15
US20020165272A1 (en) 2002-11-07
DK1401424T3 (da) 2007-02-26
US6541513B2 (en) 2003-04-01
MXPA03007722A (es) 2004-11-12
RS51056B (sr) 2010-10-31
CA2439480C (en) 2011-04-26

Similar Documents

Publication Publication Date Title
US7863272B2 (en) Sigma ligands for neuronal regeneration and functional recovery
RU2338537C2 (ru) СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
KR101335941B1 (ko) 수면-각성 장애의 치료
CN1262271C (zh) 用于预防或治疗精神病的氨基甲酸酯化合物
JP2008542378A (ja) 精神病性障害を管理する方法および組成物
CN1235579C (zh) 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
CN1262272C (zh) 用于预防或治疗运动障碍的氨基甲酸酯化合物
Knackstedt et al. MC-100093, a novel β-lactam glutamate transporter-1 enhancer devoid of antimicrobial properties, attenuates cocaine relapse in rats
US20140221385A1 (en) Combinations of serotonin receptor agonists for treatment of movement disorders
CN1849116A (zh) 用于治疗疼痛的氨基甲酸酯化合物
US11583543B2 (en) Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
KR101199499B1 (ko) 물질 관련 장애를 치료하는 방법
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
EP1951241A2 (en) Sigma ligands for neuronal regeneration and functional recovery
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
CN1802168A (zh) 用于神经元再生和功能恢复的σ配体
HK1131862A (en) Sigma ligands for neuronal regeneration and functional recovery

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060705

Termination date: 20120221